Screener
Shattuck Labs, Inc. STTK Business Segments — R&D
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Shattuck Labs, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 6:57 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-055483
| Revenue | Three Months Ended June 30, 2026 / $ | Three Months Ended June 30, 2026 / — | Three Months Ended June 30, 2025 / $ | Three Months Ended June 30, 2025 / — |
|---|---|---|---|---|
| Other research and development2 | 2,479 | 2,878 | ||
| Research and development non-equity compensation | 2,360 | 2,331 | ||
| Research and development equity compensation | 1,075 | 867 | ||
| Total research and development | 11,700 | 8,680 | ||
| General and administrative expenses: | ||||
| General and administrative non-equity compensation | 1,397 | 1,365 | ||
| General and administrative equity compensation | 1,658 | 1,023 | ||
| Other general and administrative including legal and accounting fees, facilities, insurance, travel and depreciation | 1,400 | 1,964 |
Item 1. Condensed Financial Statements (Unaudited)
FAQ
- What is Shattuck Labs, Inc.'s business segments — R&D?
- Shattuck Labs, Inc. (STTK) reported business segments — R&D of $11.7M in Q2 2026.
- How has Shattuck Labs, Inc.'s business segments — R&D changed year-over-year?
- Shattuck Labs, Inc.'s business segments — R&D increased by 34.8% year-over-year, from $8.68M to $11.7M.
- What is the long-term trend for Shattuck Labs, Inc.'s business segments — R&D?
- Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s business segments — R&D has grown at a -31.1% compound annual growth rate (CAGR), from $74.31M to $35.27M.
- What does business segments — R&D mean?
- Aggregates all costs incurred by the segment to advance clinical-stage product candidates, including personnel, laboratory supplies, and clinical trial expenses. It is a primary measure of the company's investment in future therapeutic breakthroughs and pipeline maturity.
Ask your AI about Shattuck Labs, Inc.'s business segments — r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude